PharmaTher Provides Product Pipeline Updates and Anticipated Milestones for Q4-2021 and 2022 Sep 13, 2021
Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104 Sep 9, 2021
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offering Sep 9, 2021
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Sep 7, 2021
Ayr Wellness Signs Definitive Agreement To Acquire Owner Of Levia Cannabis Infused Seltzers Sep 7, 2021
